Catalent
CTLT
#1737
Rank
โ‚น1.035 T
Marketcap
โ‚น5,703
Share price
0.00%
Change (1 day)
20.71%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น30.09 Billion

According to Catalent's latest financial reports the company has โ‚น30.09 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30โ‚น22.97 B-45.91%
2022-06-30โ‚น42.48 B-40.93%
2021-06-30โ‚น71.91 B-0.38%
2020-06-30โ‚น72.18 B203.16%
2019-06-30โ‚น23.81 B-15.19%
2018-06-30โ‚น28.07 B41.57%
2017-06-30โ‚น19.83 B111.98%
2016-06-30โ‚น9.35 B-2.76%
2015-06-30โ‚น9.62 B115.64%
2014-06-30โ‚น4.46 B-29.55%
2013-06-30โ‚น6.33 B-17.92%
2012-06-30โ‚น7.71 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚น25.25 B-16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น15.49 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น183.81 B 510.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚น28.99 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA